QSI
Quantum-Si incorporated
Healthcare — Medical Devices
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Price History
Fundamentals
| Market Cap | $201.23M |
| P/E Ratio (TTM) | - |
| Forward P/E | -2.57 |
| EPS (TTM) | $-0.50 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | -69.40% |
| ROE | -46.38% |
| Debt/Equity | 1.85 |
| Recommendation | None |
| Analyst Target | $2.50 |
| Analysts | 3 |
| Next Earnings | Aug 13, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 47.6 |
| Beta | 3.17 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $3.10 |
| 52-Week Low | $0.69 |
| 50-Day Avg | $0.98 |
| 200-Day Avg | $1.22 |
| Avg Volume | $6.31M |
| Volume | $5.49M |
Performance Analysis
NEUTRALQSI presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:28 UTC
Back to Screener Export Report